Health State Utility Mapping of Rimegepant for the Preventive Treatment of Migraine: Double-Blind Treatment Phase and Open Label Extension (BHV3000-305).
Lauren C PowellGilbert L'ItalienEvan PopoffKarissa JohnstonFiona O'SullivanLinda HarrisRobert CroopVladimir CoricRichard B LiptonPublished in: Advances in therapy (2022)
NCT03732638.